1 document found, page 1 of 1

Sort by Issue Date

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellul...

Zhang, Yafei; Zhang, Bicheng; Zhang, Anran; Zhao, Yong; Zhao, Jie; Liu, Jian; Gao, Jianfei; Fang, Dianchun; Rao, Zhiguo

OBJECTIVE: Sorafenib is an oral multikinase inhibitor that has been proven effective as a single-agent therapy in hepatocellular carcinoma, and there is a strong rationale for investigating its use in combination with other agents. Vitamin K2 is nearly non-toxic to humans and has been shown to inhibit the growth of hepatocellular carcinoma. In this study, we evaluated the effects of a combination of sorafenib a...

Date: 2012   |   Origin: Oasisbr

1 Results

Queried text

Refine Results

Author










Date


Document Type


Access rights


Resource


Subject